THC Farmaceuticals, Inc.
CBDG
$0.013
-$0.0011-7.80%
OTC PK
| 06/30/2015 | 03/31/2015 | ||||
|---|---|---|---|---|---|
| Revenue | -6.25% | 9.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.25% | 9.09% | |||
| Cost of Revenue | 0.00% | 80.00% | |||
| Gross Profit | -100.00% | -84.21% | |||
| SG&A Expenses | 79.59% | 90.29% | |||
| Depreciation & Amortization | -33.33% | 50.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 63.52% | 89.15% | |||
| Operating Income | -81.54% | -129.41% | |||
| Income Before Tax | -80.30% | -132.94% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -80.30% | -132.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -80.30% | -132.94% | |||
| EBIT | -81.54% | -129.41% | |||
| EBITDA | -81.44% | -130.95% | |||
| EPS Basic | -84.62% | -85.71% | |||
| Normalized Basic EPS | -87.50% | -100.00% | |||
| EPS Diluted | -84.62% | -85.71% | |||
| Normalized Diluted EPS | -87.50% | -100.00% | |||
| Average Basic Shares Outstanding | 0.17% | 25.06% | |||
| Average Diluted Shares Outstanding | 0.17% | 25.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||